|
🐜
|
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden
19 auth.
R. Benayed,
M. Offin,
Kerry A Mullaney,
Purvil Sukhadia,
Kelly Rios,
P. Desmeules,
R. Ptashkin,
H. Won,
Jason C. Chang,
D. Halpenny,
...
A. Schram,
C. Rudin,
D. Hyman,
M. Arcila,
M. Berger,
A. Zehir,
M. Kris,
A. Drilon,
M. Ladanyi
|
8 |
2019 |
8
🐜
|
|
🐜
|
Small Cell Lung Carcinoma Subtypes Defined by ASCL1, NEUROD1, POU2F3 and YAP1: Comprehensive Immunohistochemical and Histopathologic Characterization.
22 auth.
M. Baine,
Min-Shu Hsieh,
W. Lai,
J. Egger,
A. Jungbluth,
Yahya Daneshbod,
Yahya Daneshbod,
A. Beras,
Rowanne Spencer,
Jessica Lopardo,
...
Francis M Bodd,
J. Montecalvo,
J. Montecalvo,
J. Sauter,
Jason C. Chang,
Darren J Buonocore,
W. Travis,
T. Sen,
J. Poirier,
J. Poirier,
C. Rudin,
N. Rekhtman
|
8 |
2020 |
8
🐜
|
|
🐜
|
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
19 auth.
A. Schoenfeld,
J. Chan,
Daisuke Kubota,
Hiroki Sato,
H. Rizvi,
Y. Daneshbod,
Jason C. Chang,
P. Paik,
M. Offin,
M. Arcila,
...
M. Davare,
U. Shinde,
D. Pe’er,
N. Rekhtman,
M. Kris,
R. Somwar,
Gregory Riely,
M. Ladanyi,
H. Yu
|
7 |
2020 |
7
🐜
|
|
🐜
|
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
22 auth.
N. Rekhtman,
J. Montecalvo,
Jason C. Chang,
D. Alex,
R. Ptashkin,
Ni Ai,
J. Sauter,
Brie E. Kezlarian,
A. Jungbluth,
P. Desmeules,
...
A. Beras,
J. Bishop,
A. Plodkowski,
M. Gounder,
A. Schoenfeld,
A. Namakydoust,
Bob T. Li,
C. Rudin,
Gregory Riely,
David R. Jones,
M. Ladanyi,
W. Travis
|
7 |
2019 |
7
🐜
|
|
🐬
|
MET-dependent solid tumours — molecular diagnosis and targeted therapy
Robin Guo,
Jia Luo,
Jason C. Chang,
N. Rekhtman,
M. Arcila,
A. Drilon
|
7 |
2020 |
7
🐬
|
|
🐜
|
Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)‐Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis
11 auth.
T. Eguchi,
Koji Kameda,
Shaohua Lu,
M. Bott,
K. Tan,
J. Montecalvo,
...
Jason C. Chang,
N. Rekhtman,
David R. Jones,
W. Travis,
P. Adusumilli
|
7 |
2019 |
7
🐜
|
|
🐜
|
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.
26 auth.
A. Drilon,
R. Somwar,
Biju Mangatt,
H. Edgren,
P. Desmeules,
A. Ruusulehto,
Roger S Smith,
L. Delasos,
M. Vojnic,
A. Plodkowski,
J. Sabari,
K. Ng,
J. Montecalvo,
Jason C. Chang,
Huichun Tai,
...
W. Lockwood,
Victor D. Martinez,
Gregory Riely,
C. Rudin,
M. Kris,
M. Arcila,
C. Matheny,
R. Benayed,
N. Rekhtman,
M. Ladanyi,
G. Ganji
|
7 |
2018 |
7
🐜
|
|
🐜
|
The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer
23 auth.
A. Schoenfeld,
C. Bandlamudi,
J. Lavery,
J. Montecalvo,
A. Namakydoust,
H. Rizvi,
J. Egger,
Carla P. Concepcion,
S. Paul,
M. Arcila,
...
Y. Daneshbod,
Jason C. Chang,
J. Sauter,
A. Beras,
M. Ladanyi,
T. Jacks,
C. Rudin,
B. Taylor,
M. Donoghue,
G. Heller,
M. Hellmann,
N. Rekhtman,
Gregory Riely
|
7 |
2020 |
7
🐜
|
|
🐜
|
Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers.
18 auth.
M. Offin,
R. Somwar,
N. Rekhtman,
R. Benayed,
Jason C. Chang,
A. Plodkowski,
A. Lui,
J. Eng,
M. Rosenblum,
Bob T. Li,
...
Gregory Riely,
C. Rudin,
M. Kris,
W. Travis,
A. Drilon,
M. Arcila,
M. Ladanyi,
H. Yu
|
6 |
2018 |
6
🐜
|
|
🐜
|
Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies
18 auth.
J. Sauter,
M. Baine,
K. Butnor,
Darren J Buonocore,
Jason C. Chang,
A. Jungbluth,
M. Szabolcs,
S. Morjaria,
S. Mount,
N. Rekhtman,
...
E. Selbs,
Z. Sheng,
Yongli Xiao,
D. Kleiner,
S. Pittaluga,
J. Taubenberger,
A. Rapkiewicz,
W. Travis
|
6 |
2020 |
6
🐜
|
